Comerica Bank Lowers Stock Holdings in Masimo Corporation $MASI

Key Points

• Comerica Bank cut its stake in Masimo by 94.8%, selling 221,194 shares and retaining 12,233 shares worth about $1.59 million at the end of the quarter.
• Several large institutional investors—including Viking Global, Squarepoint, UBS, Alyeska, and Westfield—added or boosted positions, leaving institutional ownership at about 85.96% of the company.
• Masimo trades near $178.50 with a market cap of $9.35 billion, and analysts have an average rating of Hold with a consensus target price of $180.40.

Comerica Bank decreased its position in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 94.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,233 shares of the medical equipment provider's stock after selling 221,194 shares during the quarter. Comerica Bank's holdings in Masimo were worth $1,591,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Viking Global Investors LP bought a new stake in shares of Masimo in the 2nd quarter worth about $129,096,000. Squarepoint Ops LLC increased its position in shares of Masimo by 738.8% during the third quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider's stock worth $91,619,000 after acquiring an additional 546,905 shares during the period. UBS Group AG increased its position in shares of Masimo by 252.9% during the fourth quarter. UBS Group AG now owns 599,274 shares of the medical equipment provider's stock worth $77,942,000 after acquiring an additional 429,474 shares during the period. Alyeska Investment Group L.P. boosted its stake in shares of Masimo by 21.7% during the third quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider's stock valued at $203,779,000 after purchasing an additional 246,595 shares in the last quarter. Finally, Westfield Capital Management Co. LP boosted its stake in shares of Masimo by 20.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider's stock valued at $209,410,000 after purchasing an additional 238,047 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

Masimo Stock Up 0.0%

Shares of NASDAQ:MASI opened at $178.50 on Friday. Masimo Corporation has a 1-year low of $125.94 and a 1-year high of $179.00. The stock has a market cap of $9.35 billion, a P/E ratio of -16.94, a P/E/G ratio of 1.81 and a beta of 1.13. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.47. The firm has a fifty day moving average price of $177.41 and a 200 day moving average price of $154.63.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on MASI. Wells Fargo & Company raised shares of Masimo to a "hold" rating in a report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. BTIG Research lowered shares of Masimo from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 18th. Weiss Ratings upgraded shares of Masimo from a "sell (d-)" rating to a "hold (c-)" rating in a report on Wednesday. Finally, Wolfe Research downgraded shares of Masimo from a "strong-buy" rating to a "hold" rating in a research note on Thursday, February 19th. Nine research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Masimo currently has an average rating of "Hold" and a consensus target price of $180.40.

Masimo Company Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.